By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS

Vanda is a specialty pharmaceutical company focused on the development and commercialization of novel therapies to address high unmet medical needs and improve the lives of patients.

YEAR FOUNDED:

2002

LEADERSHIP:

Founders: Mihael Hristos Polymeropoulos, Argeris Karabelas

CEO: Mihael Hristos Polymeropoulos

CFO: James Kelly

JOBS:

Please click here for Vanda job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Products


Key Statistics


Email:
Ownership: Public

Web Site: Vanda
Employees:
Symbol: VNDA
 



Industry
Pharmaceutical






Company News
Vanda (VNDA) Release: USPTO Dismisses Petition For Inter Partes Review Of Fanapt Patent 8/31/2016 9:20:19 AM
Vanda (VNDA) Investors Elated Over Drug Patent Ruling 8/26/2016 6:56:56 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: HETLIOZ Is Now Available For The Treatment Of Non-24-Hour Sleep-Wake Disorder In Germany 8/1/2016 8:59:21 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Second Quarter 2016 Financial Results 7/28/2016 6:43:42 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Second Quarter 2016 Financial Results On July 27, 2016 7/13/2016 6:35:29 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The JMP Securities Life Sciences Conference 6/21/2016 7:40:47 AM
Vanda Pharmaceuticals, Inc. (VNDA) Release: FDA Grants Fanapt Three Years Of Marketing Exclusivity for Labeling Changes Relating To Maintenance Treatment Of Schizophrenia 6/16/2016 11:38:17 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Present At The Jefferies 2016 Healthcare Conference 6/3/2016 8:12:08 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces FDA Approval Of The Fanapt Supplemental New Drug Application For Maintenance Treatment Of Schizophrenia In Adults 5/27/2016 6:20:32 AM
3 Biotech Stocks Investors Should Pick Up in May 5/17/2016 7:09:10 AM
12345678910...
//-->